Target Price | $47.00 |
Price | $29.36 |
Potential |
60.08%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Aeglea BioTherapeutics Inc 2025 .
The average Aeglea BioTherapeutics Inc target price is $47.00.
This is
60.08%
register free of charge
$54.00
83.92%
register free of charge
$40.00
36.24%
register free of charge
|
|
A rating was issued by 9 analysts: 9 Analysts recommend Aeglea BioTherapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Aeglea BioTherapeutics Inc stock has an average upside potential 2025 of
60.08%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -49.12 | -3.64 |
97.59% | 92.59% | |
P/E | negative | |
EV/Sales | 306.21 |
8 Analysts have issued a Aeglea BioTherapeutics Inc forecast for earnings per share. The average Aeglea BioTherapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Aeglea BioTherapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.